Literature DB >> 11835371

Dopaminergic modulation of cortical function in patients with Parkinson's disease.

Venkata S Mattay1, Alessandro Tessitore, Joseph H Callicott, Alessandro Bertolino, Terry E Goldberg, Thomas N Chase, Thomas M Hyde, Daniel R Weinberger.   

Abstract

Patients with idiopathic Parkinson's disease suffer not only from classic motor symptoms, but from deficits in cognitive function, primarily those subserved by the prefrontal cortex as well. The aim of the current study was to investigate the modulatory effects of dopaminergic therapy on neural systems subserving working memory and motor function in patients with Parkinson's disease. Ten patients with stage I and II Parkinson's disease were studied with functional magnetic resonance imaging, during a relatively hypodopaminergic state (ie, 12 hours after a last dose of dopamimetic treatment), and again during a dopamine-replete state. Functional magnetic resonance imaging was performed under three conditions: a working memory task, a cued sensorimotor task and rest. Consistent with prior data, the cortical motor regions activated during the motor task showed greater activation during the dopamine-replete state; however, the cortical regions subserving working memory displayed greater activation during the hypodopaminergic state. Interestingly, the increase in cortical activation during the working memory task in the hypodopaminergic state positively correlated with errors in task performance, and the increased activation in the cortical motor regions during the dopamine-replete state was positively correlated with improvement in motor function. These results support evidence from basic research that dopamine modulates cortical networks subserving working memory and motor function via two distinct mechanisms: nigrostriatal projections facilitate motor function indirectly via thalamic projections to motor cortices, whereas the mesocortical dopaminergic system facilitates working memory function via direct inputs to prefrontal cortex. The results are also consistent with evidence that the hypodopaminergic state is associated with decreased efficiency of prefrontal cortical information processing and that dopaminergic therapy improves the physiological efficiency of this region.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11835371     DOI: 10.1002/ana.10078

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  116 in total

Review 1.  Imaging and biological function in health and disease.

Authors:  Joy Hirsch
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 2.  Strategies for stroke rehabilitation.

Authors:  Bruce H Dobkin
Journal:  Lancet Neurol       Date:  2004-09       Impact factor: 44.182

3.  The role of prefrontal dopamine D1 receptors in the neural mechanisms of associative learning.

Authors:  M Victoria Puig; Earl K Miller
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

Review 4.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

5.  Attention and reach-to-grasp movements in Parkinson's disease.

Authors:  Cathy Lu; Aamir Bharmal; Zelma H Kiss; Oksana Suchowersky; Angela M Haffenden
Journal:  Exp Brain Res       Date:  2010-06-29       Impact factor: 1.972

Review 6.  The many facets of motor learning and their relevance for Parkinson's disease.

Authors:  Lucio Marinelli; Angelo Quartarone; Mark Hallett; Giuseppe Frazzitta; Maria Felice Ghilardi
Journal:  Clin Neurophysiol       Date:  2017-04-09       Impact factor: 3.708

7.  Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence.

Authors:  D Tomasi; R Z Goldstein; F Telang; T Maloney; N Alia-Klein; E C Caparelli; N D Volkow
Journal:  Brain Res       Date:  2007-08-10       Impact factor: 3.252

Review 8.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Dissociable dorsal and ventral frontostriatal working memory circuits: evidence from subthalamic stimulation in Parkinson's disease.

Authors:  Jocelyne Ventre-Dominey; Stéphanie Bourret; Hélène Mollion; Emmanuel Broussolle; Peter Ford Dominey
Journal:  Hum Brain Mapp       Date:  2012-10-25       Impact factor: 5.038

Review 10.  Preventing neurocognitive late effects in childhood cancer survivors.

Authors:  Martha A Askins; Bartlett D Moore
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.